Editorial Comment on: Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries

European Urology

Volumn 55, Issue 4, 2009, Pages 967-968

  Jannini, Emmanuele A ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DAPOXETINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION; HUMAN; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL INTERCOURSE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 60249096300     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.01.026     Document Type: Note

References (5)

1. Buvat J., Tesfaye F., Rothman M., Rivas D.A., and Giuliano F. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 55 (2009) 957-968
2. Jannini E.A., and Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol 23 (2005) 68-75
3. Screponi E., Carosa E., Di Stasi S.M., Pepe M., Carruba G., and Jannini E.A. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58 (2001) 198-202
4. Carani C., Isidori A.M., Granata A., et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 90 (2005) 6472-6479
5. Jannini E.A., Simonelli C., and Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl 25 (2002) 317-323